Not finding it? Sign in to also search OpenAlex live.
-
DOP28 Yield of surveillance colonoscopy in patients with Primary Sclerosing Cholangitis2024 Journal of Crohn s and Colitis conference-abstract Medicine Colorectal Cancer Screening and Detection Open access
Natasja van de Pol, Bregje Mol, Marin J. de Jong, Rinse Karel Weersma, Akin Inderson, Floor C. Slooter, +4 more
0citations -
P799 Deficits in geriatric assessment are dynamic over 18 months and impacted by therapeutic treatment in older patients with Inflammatory Bowel Disease2024 Journal of Crohn s and Colitis conference-abstract Medicine Frailty in Older Adults Open access
Anne B. Fons, Vera E. R. Asscher, Rogier J. L. Stuyt, Martine A.M.C. Baven-Pronk, Sander van der Marel, Rutger J. Jacobs, +4 more
0citations -
P055 GPR43 and GPR84 play a crucial role in supporting perianal fistula formation and disease progression in Crohn’s Disease2024 Journal of Crohn s and Colitis conference-abstract Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Federica Rubbino, Alessio di Cristofaro, Samuel Elias Pineda Chavez, Marieke Heijink, Martin A. Giera, Annalisa Maroli, +8 more
0citations -
P037 Modelling gut complexity and disease: development of a next-generation adult stem cell based tubular gut-on-a-chip model2024 Journal of Crohn s and Colitis conference-abstract Engineering 3D Printing in Biomedical Research Open access
Kinga Kosim, Marleen Bokkers, Jessica Oudshoorn, Teddie van Heusden, Dorota Kurek, Jos Joore, +1 more
0citations -
P946 Real life management of patients with active perianal fistulizing Crohn’s disease (ALERT-CD study)2024 Journal of Crohn s and Colitis conference-abstract Medicine Anorectal Disease Treatments and Outcomes Open access
Laurents P. S. Stassen, Christianne Johanna Buskens, A. Pronk, Jarmila van der Bilt, Krisztina Barbara Gecse, Nanne K.H. de Boer, +20 more
0citations -
P184 Disease activity in Inflammatory Bowel Disease patients is associated with increased liver fat content during follow-up2021 Journal of Crohn s and Colitis conference-abstract Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Emilie van Lingen, ME Tushuizen, Maurice Steenhuis, T. van Deynen, Jennifer Martens, Diego Morales, +4 more
0citations -
P819 Postoperative prophylaxis prevents surgical and severe endoscopic recurrence after primary ileocecal resection in CD patients2024 Journal of Crohn s and Colitis conference-abstract Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Sebastiaan ten Bokkel Huinink, Evelien M. J. Beelen, Nicole Stephanie Erler, Frank Hoentjen, Alexander G L Bodelier, Gerard D. H. Dijkstra, +6 more
0citations -
P930 Rapid symptomatic improvement with subcutaneous infliximab induction treatment for patients with moderate-to-severe Crohn’s disease: first results from the DIRECT-CD study2024 Journal of Crohn s and Colitis conference-abstract Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease
Suzanne I. Anjie, Bindia Jharap, Jeroen M. Jansen, Wout Mares, Marjolijn Duijvestein, Jeroen Maljaars, +3 more
0citations -
P097 Abnormal frailty screening is independently associated with both all-cause and disease-related hospital admissions in older patients with inflammatory bowel diseases2021 Journal of Crohn s and Colitis conference-abstract Medicine Frailty in Older Adults Open access
Vera E. R. Asscher, Sanne N. Waars, Jesse Fens, Monse W. M. Wieland, A van der Meulen-de Jong, Rogier J. L. Stuyt, +7 more
0citations -
P079 High-dimensional mass cytometry after local MSC treatment in patients with refractory proctitis shows an effect on the myeloid compartment: preliminary data2020 Journal of Crohn s and Colitis conference-abstract Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Laura F. Ouboter, Marieke C. Barnhoorn, Lukas J.A.C. Hawinkels, Melissa van Pel, Jaap Jan Zwaginga, Hein W. Verspaget, +3 more
0citations -
P0860 Long-term outcomes of extended versus conventional adalimumab dose interval for patients with Crohn’s disease in stable remission: 3-year follow-up of the randomized controlled LADI trial
Lisa M.A. van Lierop, Robbart van Linschoten, Fenna M. Jansen, Nathan den Broeder, Alexander G L Bodelier, Ingrid A. M. Gisbertz, +17 more
0citations -
P0396 Combined clinical and histopathological risk stratification for prediction of (severe) endoscopic postoperative recurrence in patients with Crohn’s disease after ileocolic resection
Lindsey Oudijk, Ariadne H.A.G. Ooms, Evelien M. J. Beelen, Jarmila D.W. van der Bilt, Mariëlle J. L. Romberg-Camps, Gerard D. H. Dijkstra, +16 more
0citations -
OP14 The United European Gastroenterology green paper—climate change and gastroenterology2025 Journal of Crohn s and Colitis conference-abstract Environmental Science Climate Change and Health Impacts
Marjolijn Duijvestein, Reena Sidhu, Katharina Zimmermann, Emma Victoria Carrington, Alexander Hann, Paula Sousa, +2 more
0citations -
P818 Imaging-based preoperative body composition is associated with the risk of postoperative complications and postoperative endoscopic recurrence in patients with Crohn’s disease2024 Journal of Crohn s and Colitis conference-abstract Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
K Demers, Oddeke van Ruler, Marie J. Pierik, J D W van der Bilt, Mariëlle J. L. Romberg-Camps, Gerard D. H. Dijkstra, +19 more
0citations -
P228 Prehabilitation strategies prior to ileocolonic resection in Crohn’s disease in a prospective cohort study: a missed window of opportunity?2021 Journal of Crohn s and Colitis conference-abstract Medicine Enhanced Recovery After Surgery Open access
Marit F.E. Ruiterkamp, Jeanine Hubertina Catharina Arkenbosch, Oddeke van Ruler, Sander van der Marel, KW van Dongen, Jeroen Maljaars, +7 more
0citations -
P810 Geriatric impairments in older inflammatory bowel disease patients are associated with higher disease burden: results of a multicentre cohort study2020 Journal of Crohn s and Colitis conference-abstract Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease
Vera E. R. Asscher, Sanne N. Waars, A van der Meulen-de Jong, Rogier J. L. Stuyt, Sandra Brouwer, Sander van der Marel, +4 more
0citations -
P126 The predictive value of the modified Rutgeerts score at index endoscopy after primary ileocolic resection in patients with Crohn’s disease for the risk of re-resection and severe endoscopic inflammation after long-term follow-up2022 Journal of Crohn s and Colitis conference-abstract Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Oddeke van Ruler, Alexander G L Bodelier, Gerard D. H. Dijkstra, Mariëlle J. L. Romberg-Camps, Nanne K.H. de Boer, Frank Hoentjen, +3 more
0citations -
P317 Ustekinumab Trough Concentrations Associated with Biochemical Outcomes in Patients with Crohn’s Disease2022 Journal of Crohn s and Colitis conference-abstract Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease
Tessa Straatmijer, Vince B. C. Biemans, Dirk Jan A. R. Moes, Frank Hoentjen, Rob ter Heine, Jeroen Maljaars, +3 more
0citations -
P340 Comorbidity is associated with safety outcomes in vedolizumab- and ustekinumab-treated inflammatory bowel disease patients2020 Journal of Crohn s and Colitis conference-abstract Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Vera E. R. Asscher, Vince B. C. Biemans, Gerard D. H. Dijkstra, A van der Meulen-de Jong, Mark Löwenberg, Sander van der Marel, +8 more
0citations -
DOP85 The role of fibroblasts in the pathogenesis of Crohn’s disease-associated fistulas and in mesenchymal stem cell therapy2020 Journal of Crohn s and Colitis conference-abstract Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Ramona S. Bruckner, Marieke C. Barnhoorn, Hailiang Mei, Szymon M. Kiełbasa, T J Harrijvan, Sarah K. Hakuno, +3 more
0citations -
P388 Prediction model to safely CEASE anti-TNF therapy in Crohn’s disease: validation of a predictive diagnostic tool for the cessation of anti-TNF treatment in CD in a Dutch population2020 Journal of Crohn s and Colitis conference-abstract Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Sebastiaan ten Bokkel Huinink, D. de Jong, Janneke van der Woude, Daan Nieboer, Ewout Willem Steyerberg, Frank H.J. Wolfhagen, +14 more
0citations -
P0670 Efficacy of subcutaneous guselkumab induction therapy by baseline demographics and concomitant medications in participants with moderately to severely active Crohn’s disease: Results from the phase 3 GRAVITI study2025 Journal of Crohn s and Colitis conference-abstract Medicine Inflammatory Bowel Disease Open access
Ailsa L Hart, Tadakazu Hisamatsu, Flávio Steinwurz, Geert D’Haens, Wei Yong Liu, Mobolaji Olurinde, +6 more
0citations -
P0843 Efficacy by baseline disease characteristics of subcutaneous guselkumab induction therapy in patients with moderately to severely active Crohn’s disease: Results at Week 12 from the phase 3 GRAVITI study
Geert D’Haens, Flávio Steinwurz, Ailsa L Hart, Wei Yong Liu, Mobolaji Olurinde, P Ngqawa, +5 more
0citations -
P0872 Corticosteroid sparing effects of treatment with guselkumab in patients with moderately to severely active Crohn’s disease: Phase 3 GRAVITI study results through week 482025 Journal of Crohn s and Colitis conference-abstract Medicine Inflammatory Bowel Disease Open access
A Hart, Remo Panaccione, Flavio Steinwurz, Qian Cao, Tadakazu Hisamatsu, Stéphane Nancey, +5 more
0citations